Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4/A Grant or award Director acquired 66,218 shares (grant or award)
  2. 4 Grant or award Director acquired 70,467 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 70,113 shares (grant or award)
  6. 4 Grant or award Director acquired 66,218 shares (grant or award)
  7. 4 Grant or award Director acquired 84,986 shares (grant or award)
  8. 4 Grant or award Director acquired 65,156 shares (grant or award)
  9. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.71 ($3,542)
  10. 4 Open-market buy 10% owner bought 4,750,000 shares at $0.80 ($3,800,000)
  11. 4 Open-market buy 10% owner bought 5,000,000 shares at $0.80 ($4,000,000)
  12. 4 Open-market buy President and CEO bought 37,500 shares at $0.80 ($30,000)
  13. 4 Open-market sale Director sold 10,000 shares at $1.10 ($11,000)
  14. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.26 ($6,292)
  15. 4/A Grant or award Director acquired 45,455 shares (grant or award)
  16. 4/A Grant or award Director acquired 34,848 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 35,417 shares (grant or award)
  20. 4 Grant or award Director acquired 37,689 shares (grant or award)

Page 11 of 28 · 551 filings